Form 4 for ELTX Elicio Therapeutics, Inc.
Accepted 2022-05-27 00:00:00 ET · period of report 2022-05-25 · accession 0001601485-22-000043 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-27 | 2022-05-25 | ELTX | Venkatesan Jay | See Remarks, Dir | P - Purchase | $1.25 | +11.3K | 1.89M | +0.6% | +$14.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-25 | P | A | 11,313 | $1.25 | 1,891,947 | D | — | — |